Ignyte Acquisition (Ignyte Acquisition) Common Stock : $57.50 Mil (As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Ignyte Acquisition Common Stock?

Ignyte Acquisition's quarterly common stock stayed the same from Dec. 2021 ($57.50 Mil) to Mar. 2022 ($57.50 Mil) and stayed the same from Mar. 2022 ($57.50 Mil) to Jun. 2022 ($57.50 Mil).

Ignyte Acquisition's annual common stock stayed the same from . 20 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($57.50 Mil).

Ignyte Acquisition Common Stock Historical Data

The historical data trend for Ignyte Acquisition's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ignyte Acquisition Common Stock Chart

Ignyte Acquisition Annual Data

Trend

Dec20

Dec21

Common Stock

57.50

Ignyte Acquisition Quarterly Data
	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Common Stock	Get a 7-Day Free Trial			51.30	57.51	57.50	57.50	57.50

Ignyte Acquisition Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Ignyte Acquisition (Ignyte Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Ignyte Acquisition Corp (NAS:IGNY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

640 5th Avenue, 4th Floor, New York, NY, USA, 10019

Website

https://ignytespac.com

Ignyte Acquisition Corp is a blank check company.

Executives

Richard J Rosenstock	director	C/O GAINES BERLAND INC, 1055 STEWART AVENUE, BETHPAGE NY 11714
Cheryl Cohen	director	C/O MEDIVATION, INC., 201 SPEAR ST., 3RD FLOOR, SAN FRANCISCO CA 94105
Charles Wilson	director	C/O UNUM THERAPEUTICS, 200 CAMBRIDGEPARK DR., STE. 3100, CAMBRIDGE MA 02140
Ignyte Sponsor Llc	10 percent owner	640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David I. Rosenberg	director, 10 percent owner, officer: Co-Chief Executive Officer	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
John Andrew Boockvar	director	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
David J. Strupp	director, 10 percent owner, officer: Co-Chief Executive Officer	107 DUNNING ROAD, NEW CANAAN CT 06840
Steven Neil Kaplan	director, officer: Chief Financial Officer	C/O IGNYTE ACQUISITION CORP., 640 5TH AVENUE, 4TH FLOOR, NEW YORK NY 10019
Deerfield Management Company, L.p. (series C)	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p.	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Partners, L.p.	10 percent owner, other: Possible Member of 10% Group	345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017